Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumit Rawal

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos One|July 1, 2014
Response of the hepatic transcriptome to aflatoxin B1 in domestic turkey (Meleagris gallopavo)Melissa S Monson, Robert E Settlage, Kevin W McMahon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2012
Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenograftsMark D Walsh, Suzan K Hanna, Jeremy Sen, et al.
Research in Veterinary Science|July 7, 2014
Aflatoxicosis chemoprevention by probiotic Lactobacillius and lack of effect on the major histocompatibility complexSumit Rawal, Miranda M Bauer, Kristelle M Mendoza, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 11, 2012
Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograftKevin S Chu, Warefta Hasan, Sumit Rawal, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|July 1, 2014
Response of the hepatic transcriptome to aflatoxin B1 in domestic turkey (Meleagris gallopavo)Melissa S Monson, Robert E Settlage, Kevin W McMahon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2012
Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenograftsMark D Walsh, Suzan K Hanna, Jeremy Sen, et al.
Research in Veterinary Science|July 7, 2014
Aflatoxicosis chemoprevention by probiotic Lactobacillius and lack of effect on the major histocompatibility complexSumit Rawal, Miranda M Bauer, Kristelle M Mendoza, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 11, 2012
Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograftKevin S Chu, Warefta Hasan, Sumit Rawal, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
Pageof 2